Journament

Keyword Connections - staphylokinase Keywords

Connection Type	Connection
Journals	bmc biotechnology yao xue xue bao = acta pharmaceutica sinica parasitology research new biotechnology biotechnology letters biotechnology progress thrombosis and haemostasis Preparative biochemistry & biotechnology Circulation Toxicologic Pathology Zhongguo shi yan xue ye xue za zhi Protein expression and purification haemostasis
Research Groups	No Research Group Connected
Bibliographies	[1] Comparison of expression optimization of new derivative of staphylokinase (SAK-2RGD-TTI) with the rSAK. [2] High-level expression of a biologically active staphylokinase in Pichia pastoris. [3] Expression of recombinant staphylokinase in the methylotrophic yeast Hansenula polymorpha. [4] Yeast extract mediated autoinduction of lacUV5 promoter: an insight. [5] [Influence of long-used staphylokinase derivative on hemoagglutinative and fibrinolytic systems]. [6] High-level expression of non-glycosylated and active staphylokinase from Pichia pastoris. [7] High yielding recombinant Staphylokinase in bacterial expression system--cloning, expression, purification and activity studies. [8] [Thrombolysis by staphylokinase in rabbits with experimental pulmonary embolus]. [9] Enhanced thrombolysis induced by argatroban or activated protein C in the presence or absence of staphylokinase, measured in an in vivo animal model using mesenteric arterioles. [10] Toxicology studies with recombinant staphylokinase and with SY 161-P5, a polyethylene glycol-derivatized cysteine-substitution mutant. [11] Molecular characterization of the histone H2A gene from the parasite Trypanosoma rangeli. [12] Outcome and one year follow-up of intra-arterial staphylokinase in 191 patients with peripheral arterial occlusion. [13] Comparative effects of tissue plasminogen activator, streptokinase, and staphylokinase on cerebral ischemic infarction and pulmonary clot lysis in hamster models. [14] Comparison of expression optimization of new derivative of staphylokinase (SAK-2RGD-TTI) with the rSAK. [15] High-level expression of a biologically active staphylokinase in Pichia pastoris. [16] Expression of recombinant staphylokinase in the methylotrophic yeast Hansenula polymorpha. [17] [Influence of long-used staphylokinase derivative on hemoagglutinative and fibrinolytic systems]. [18] High-level expression of non-glycosylated and active staphylokinase from Pichia pastoris. [19] High yielding recombinant Staphylokinase in bacterial expression system--cloning, expression, purification and activity studies. [20] [Thrombolysis by staphylokinase in rabbits with experimental pulmonary embolus]. [21] Enhanced thrombolysis induced by argatroban or activated protein C in the presence or absence of staphylokinase, measured in an in vivo animal model using mesenteric arterioles. [22] Toxicology studies with recombinant staphylokinase and with SY 161-P5, a polyethylene glycol-derivatized cysteine-substitution mutant. [23] Outcome and one year follow-up of intra-arterial staphylokinase in 191 patients with peripheral arterial occlusion. [24] Comparative effects of tissue plasminogen activator, streptokinase, and staphylokinase on cerebral ischemic infarction and pulmonary clot lysis in hamster models.